Navigation Links
Biodel Inc. to Present at Natixis Bleichroeder Hidden Gems Conference on October 8, 2007
Date:10/4/2007

essions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to secure FDA approval for our product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology; the progress or success of our research, development and clinical programs, the initiation and completion of our clinical trials, the timing of the interim analyses and the timing or success of our product candidates, particularly VIAject(TM) and VIAtab(TM); our ability to secure patents for VIAject(TM) and our other product candidates; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. The Company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.


'/>"/>
SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).../PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corpor...pany"), today announced,financial results for the ...ird Quarter 2009 Financial Highlights Include:, ...million in the prior year, period, reflectin... licensed products;, -- Gross margin increas...
(Date:11/9/2009)... 9 For more than 20 years,research...velopment of a,Brain-Computer Interface (BCI). Thi...ain and a computer. Such a system enables complete... devices in their environment just by,mental activ... supervised by,the researchers themselves to use s...
(Date:11/9/2009)...e is a research industry first, allowing veterinar...rch safety study data to be managed in one softwar...olls, NJ (PRWEB) November 9, 2009 -- Xybion Medica...stima™ VM, an integrated enterprise software...se and care of veterinary research subjects. Prist...
(Date:11/6/2009)...all/ - Microbix Biosystems Inc. (the "Company") an...F1 Certification of Annual Filings of William Gast...e Chief Financial Officer (the "Officer,s Certific...he annual audited financial statements for the yea...ially filed the annual financial statements for th...
Breaking Biology Technology:BMP Sunstone Reports Third Quarter 2009 Financial Results 2BMP Sunstone Reports Third Quarter 2009 Financial Results 3BMP Sunstone Reports Third Quarter 2009 Financial Results 4BMP Sunstone Reports Third Quarter 2009 Financial Results 5BMP Sunstone Reports Third Quarter 2009 Financial Results 6BMP Sunstone Reports Third Quarter 2009 Financial Results 7BMP Sunstone Reports Third Quarter 2009 Financial Results 8BMP Sunstone Reports Third Quarter 2009 Financial Results 9BMP Sunstone Reports Third Quarter 2009 Financial Results 10BMP Sunstone Reports Third Quarter 2009 Financial Results 11BMP Sunstone Reports Third Quarter 2009 Financial Results 12intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2
...rnerstone Therapeutics Inc. (Nasdaq: CRTX ), a s...ng, developing and commercializing significant pro...reported financial results for the year ended Dece... Full-Year 2008 Net Revenues more than doubled... , , , Income from Operations increased...
... A recent study using state-of-the-art genetic tes...alled Ambra-Lift™ by Elina™ Organic...til now only Resveratrol, a substance found in the...turally stimulate Sirtuin-1 in humans. Ambra-Lift... Kalamazoo, MI (PRWEB) March 26, 2009 -- ...
...PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,...outsourcing company serving the,pharmaceutical, bi...perations,in China and the United States, today an...nd full-year 2008. , (Logo: http://www.newscom...ights, -- Total Company(1) Full-Year 2008 Net R...
Other Biology Technology:Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 2Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 3Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 4Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 5Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 6Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 7Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 8Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 9Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 10Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 11Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results 12Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 2Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 3Genomic Study Shows Organic Skin Care Product Activates Key Anti-Aging Gene 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results 20
(Date:11/9/2009)... 9 CBS Vision, the research divisi...nicom Media Group company, today announced a new r...access to the CBS Television City research facilit..., The new venture, which marries the capabilities...encies, will be called Communications Lab@OMD . ,...
(Date:11/9/2009)...tion method that begins by soaking corn kernels ra...f ethanol and more usable co-products, giving etha...ut 20 percent. , "The conventional ethanol produ...llers dried grains with soluble, it doesn,t have a... Agricultural Engineer Esha Khullar. "Whereas in b...
(Date:11/9/2009)...r, the hopeful news is that pediatric survival rat...ad newstreatments that enable survival often cause... have reached puberty currently have an opportunit...ancer treatment, they may have their semen frozen ...r, do not produce sperm, although their testicular...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Wet ethanol production process yields more ethanol and more co-products 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3For OCD Not Helping Might Be Best 50750 1For OCD Not Helping Might Be Best 50750 2Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention 50745 1Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention 50745 2Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 1Smart for Life 28TM 29 Introduces HeroFiber 28TM 29 to Its Product Line 50740 2
...ic fungi as model systems for understanding fungal... new work that offers insight into how carbon diox...ow pathogenic fungi to survive in different enviro... new evidence for how CO2 sensing and metabolism u... the growth and sexual reproduction of pathogenic ...
...lication of an fMRI (functional magnetic resonance... of Pennsylvania School of Medicine have, for the ...chological stress in a healthy human brain. , Thei...Neuroimaging, provides a neuro-imaging marker of p... the development of improved strategies for preven...
...ience fiction, but New Mexico State University res...ogy on cattle as part of a national tracking syste...a growing technological trend in cattle identifica...t NMSU,s Clayton Livestock Research Center. "It pa...and records the pattern of veins in the eye." , E...
Other Biology News:CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 2CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts 3Research Permits First-Ever Visualization of Psychological Stress in the Human Brain 2Retinal scans eyed for New Mexico show cattle 2Retinal scans eyed for New Mexico show cattle 3
Nar I from Promega
Chicken Anti-UCK2 Polyclonal Antibody, Unconjugated from Abcam
...nant Enterokinase (rEK) is a highly purified prepa...nase, a serine protease which recognizes the ident...AspLys↓) and has similar enzymatic activity. ...ified to yield the highest activity available, and...
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: